According to the New York Times, the deal PhRMA struck with the White House and Senate Finance committee this summer in exchange for its support of health reform is now apparently holding up a vote that would allow drugs to be reimported from Canada. The

This past Tuesday, PhRMA was before Congress.  Not  lobbying to block price negotiations or generic competitors, but attending a hearing in their honor (click here for details of the hearing).  Chairman Henry Waxman, of the House Energy and Commerce Commi

A group of 33 major consumer and labor organizations from 14 states are calling on the Senate to take up a cost-savings measure that would help consumers get access to well-tested, fairly priced drugs by banning anti-competitive legal deals between brand-

--by Jonas Hines The New York Times reported this weekend about a newly-approved cancer drug, Folotyn, for a deadly blood cancer. The catch? It costs about $30,000 per month. Per month. Oh, and it did not prolong life expectancy for patients (though it di

by Ann Woloson, Executive Director, Prescription Policy Choices Who’s lurking in the shadows of our kid’s computer screen? Marketers, that’s who, including drug companies offering free gifts in exchange for personal information, which in turn, is used

Last week, the New York Times reported on the dire need to improve health care on Native American Tribal Lands. Unfortunately, one of the major components of overall health and the health care system was overlooked as part of the article – oral health and

Oops! Read the Public Option Post-Mortem and Dec. 14 Health Reform Insider here. And now for something completely different, Senator McCain proclaims himself a defender of Medicare The first week of Senate debate has seemed, at times, more like Monty Pyt

New Jersey is responding to widely-shared concerns about physician-industry financial relationships with a mix of both tested and newer reforms, and its move toward greater transparency is consistent with national trends. In a report this week, the state'

On Saturday night Harry Reid, President Obama and the prospects for health reform got a big boost when the entire Democratic caucus in the Senate voted to begin debate. The vote reflected more than an agreement to get on with the business at hand. The bi